SilversidesA. Ontario's law curbing the cost of generic drugs sparks changes for pharmacies and other Canadian buyers. CMAJ2009;81: E43–E45.
2.
LewisS. Ontario generic drug wars, Part 1: How it all began. 2010. Available: www.longwoods.com/content/21910 (accessed March 30, 2011).
3.
LewisS. Ontario generic drug wars, Part 2: Did retail pharmacy need rebates?2010. Available: www.longwoods.com/content/21927 (accessed March 30, 2011).
4.
LewisS. Ontario generic drug wars, Part 3: The soul of the pharmacy profession. 2010. Available: www.longwoods.com/content/21930 (accessed March 30, 2011).
5.
LewisS. Ontario Generic Drug Wars, Part 4: Lessons for Medicare. 2010. Available: www.longwoods.com/content/21945 (accessed March 30, 2011).
6.
Canadian Pharmacists Association. Canadian Pharmacists Association responds to Health Minister's letter on the Ontario drug reform proposals. Available: www.newswire.ca/en/releases/archive/May2010/03/c7996.html. Toronto (ON): CNW; 2010.
ClancyCMCroninK. Evidence-based decision making: global evidence, local decisions. Health Affairs2005;24(1):151–62.
9.
FretheimASchunemannHJOxmanAD. Improving the use of research evidence in guideline development: 3. Group composition and consultation process. Health Res Policy Syst2006;4:15.
10.
GuyattGHOxmanADKunzR. Going from evidence to recommendations. BMJ2008;336(7652):1049–51.
GuyattGHOxmanADVistGE. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924–6.
13.
GuyattGOxmanADAklEA. GRADE guidelines: 1. Introduction — GRADE evidence profiles and summary of findings tables. J Clin Epidemiol2011;64(4):383–94.
14.
WestSKingVCareyTS. Systems to rate the strength of scientific evidence. Evidence Report/Technology Assessment No. 47. AHRQ Publication No. 02-EO16. Rockville (MD): Agency for Healthcare Research and Quality; 2002.
15.
JaeschkeRGuyattGHDellingerP. Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ2008;337:a744.